Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer
Clinical trial NCT07085273 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07085273
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2026-12-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.